early diagnosis of RA and a treat-to-target approach) were included in the evidence report and may be less generalizable than more recently completed studies. Although broad expertise was recruited and an extensive list of interventions was considered in this guideline, we could not ensure expertise in every area of integrative RA management or consider all possible integrative interventions. For example, members of the Patient Panel inquired about use of cannabinoids as an RA treatment, given the rising prevalence of their use in rheumatic diseases Sciences University In summary, this guideline outlines initial recommendations on the management of RA with exercise, rehabilitation, diet, and additional integrative interventions. These recommendations complement existing pharmacologic treatment guidelines that instruct on the use of DMARDs and, taken together, can guide a shared decision-making approach between the individual with RA and their clinician. Interprofessional treatment